FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39945711000001104: Tralokinumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Sep 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1984941000001116 Tralokinumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1984951000001118 Tralokinumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tralokinumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tralokinumab 150mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Tralokinumab Inferred relationship Existential restriction modifier
Tralokinumab 150mg/1ml solution for injection pre-filled syringes 4 pre-filled disposable injection Has specific active ingredient True Tralokinumab Inferred relationship Existential restriction modifier
Adtralza 150mg/1ml solution for injection pre-filled syringes (LEO Pharma) 4 pre-filled disposable injection 2 x 2 pre-filled syringes Has specific active ingredient True Tralokinumab Inferred relationship Existential restriction modifier
Adtralza 150mg/1ml solution for injection pre-filled syringes (LEO Pharma) Has specific active ingredient True Tralokinumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start